Vartiainen P, Jukarainen S, Rhedin S et al. Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation…
Pimenof V, Gray P, Louvanto K et al. Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts. Cell Host and Microbe 2023;31:1921-1929 https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(23)00399-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1931312823003992%3Fshowall%3Dtrue…
Akhtar Z, Götberg M, Erlinge M et al. Optimal timing of influenza vaccination among patients with acute myocardial infarction – Findings from the IAMI trial.…
McGrath L, Malhotra D, Miles A et al. Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine. JAMA Network Open 2023;6(11):…
Ernst C, Bejko D, Gaasch L et al. Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus-related hospitalizations during the initial 2023/24 season in Luxembourg.…
Tsuzuki S, Murata F. Maeda M et al. Association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015–16 to 2020–21 seasons: from…
Fontán-Vela M, Hernando V, Olmedo C et al. Effectiveness of MVA-BN vaccination in a population at high-risk of mpox: a Spanish cohort study. Clin Infect…
Zhu F, Zhong G, Huang W et al. Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged…
Jorgensen S, Drover S, Fell D et al. Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy. JAMA Pediatrics Published online October 23,…
Davies C, Skinner R. School-based vaccinations is key to reducing HPV-related diseases. HPVWorld August 2023. Nº 238 https://www.hpvworld.com/public-health/articles/school-based-vaccination-is-key-to-reducing-hpv-related-diseases/ Las autoras exponen sus experiencias en el…
December 2020 to March 2023. medRxiv 2024.01.12.24301206 https://www.medrxiv.org/content/10.1101/2024.01.12.24301206v1 Hasta marzo de 2023 54 países, áreas y territorios reportaron más de 2. 23 millones de fallecimientos por…
Aydin I, My M, Pisano F et al. Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine,…
Smolarchuk Ch, Ickert C, Zelyas N et al. Early influenza vaccine effectiveness estimates using routinely collected data, Alberta, Canada, 2023/24 season. Euro Surveill. 2024;29(2):pii=2300709 https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.2.2300709…
Drysdale S, Cathie K, Flamein F et al. Nirsevimab for Prevention of hospitalizations due to RSV in Infants. N Eg J Med 2023; 389:2425-35 https://www.nejm.org/doi/full/10.1056/NEJMoa2309189…
López Zambrano A, Caso Pita C, Fernández Escribano M et al. Factors associated to influenza vaccination among hospital’s healthcare workers in the Autonomous Community of…
Kenmoe S, Chu H, Dawood F et al. Burden of respiratory syncytial virus-associated acute respiratory infections during pregnancy. J Infect Dis published on line October…
Overduin L, Koopman J, Prins C et al. Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trial. Lancet Infect Dis published…
Regan A, Moore H, Binks M et al. Maternal Pertussis Vaccination, Infant Immunization, and Risk of Pertussis. Pediatrics 2023;152 (5): e2023062664 http://publications.aap.org/pediatrics/article-pdf/doi/10.1542/peds.2023-062664/1535986/peds.2023-062664.pdf Estudio poblacional de…
Schuster J, Hamdan L, Dulek D et al. The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated…
Lee I, Nachbagauer R, Ensz D et al. Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine…
Feldman R, Antonelli-Incalzi R, Steenackers K et al. Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions. Clinical…
Barnabas R, Brown E, Onono M et al. Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results. Nature Medicine published…
Leroux-Roels I, Van Ranst M, Vandermeulen C et al. Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older…
Bruni L, Albero G, Rowley J et al. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet…
Palache A, Kenneth Billingsley J, MacLaren K et al. Lessons learned from the COVID-19 pandemic for improved influenza control. Vaccine 2023;41:5877-5883 https://www.sciencedirect.com/science/article/pii/S0264410X2300960X A propósito de…
Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.
Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.
Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.
